3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
15
Neoplasms
11
Multiple Myeloma
9
Colorectal Neoplasms
8
Myelodysplastic Syndromes
7
Leukemia, Myeloid, Acute
6
Glioblastoma
5
Sarcoma
4
Prostatic Neoplasms
4
Neoplasms, Plasma Cell
4
Leukemia, Myelomonocytic, Chronic
4
Carcinoma, Non-Small-Cell Lung
4
Inflammation
3
Breast Neoplasms
3
Stomatitis
2
Stomach Neoplasms
2
Skin Neoplasms
2
Primary Myelofibrosis
2
Ovarian Neoplasms
2
Neoplasms by Site
2
Myofibroma
2
Myeloproliferative Disorders
2
Lymphoma
2
Lung Neoplasms
2
Liver Neoplasms
2
Leukemia
2
Glioma
2
Frailty
2
Digestive System Neoplasms
2
Digestive System Diseases
2
Interventions
Exercise
6
Transcranial Direct Current Stimulation
4
Neuropsychological Tests
4
Walking
3
Memantine
3
Tablets
2
Standard of Care
2
Patient Reported Outcome Measures
2
Methods
2
Electroencephalography
2
Donepezil
2
Cognitive Behavioral Therapy
2
mazdutide
1
lime
1
enzalutamide
1
blueberry extract
1
beta Carotene
1
acetaminophen, aspirin, caffeine drug combination
1
Vitamin E
1
Vitamin D
1
Ultraviolet Therapy
1
Transcranial Magnetic Stimulation
1
Time
1
Therapeutics
1
Tai Ji
1
Surveys and Questionnaires
1
Sugars
1
Sodium Chloride
1
Sirolimus
1
Silymarin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Cognitive Dysfunction
×
Ascorbic Acid
×
Clear all
NCT00270647
2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA
Completed
14,641 enrolled